PRIORITY AREA 3

Preclinical drug development and formulation research

This should include:

the development of standardization and analytical techniques for biomaterials.

research in physico-chemical prifiling of biomaterials (prefomulation data)

the development of advanced formulation technologies utilizing biotechnological-derived components.

research into targetted drug delivery ( spital and temporal placements).

 

 


@ Hak cipta terpelihara BIOTEK